Search Results 21-30 of 5997 for Crossover

1. Publications - Matthew M. Crowe, M.D. - Mayo Clinic

   Robotic-Assisted versus Manual Total Knee Arthroplasty in a Crossover Cohort: What Did Patients Prefer? Surg Technol Int. 2020 Nov 28; 37:336-340. View ...

2. A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine - Mayo Clinic

   Patient is eligible to receive crossover treatment according to the clinical trial protocol of the parent trial they are currently participating in.

3. Health Topics - Mayo Clinic News Network

   The World Health Organization (WHO) has declared mpox, previously called monkeypox, a public health emergency of international concern.

4. Health Topics - Mayo Clinic News Network

   The burden of cancer is different for everyone, and life stages can play a role in how it affects people. For adolescents and young adults[...] ...

5. Health Topics - Mayo Clinic News Network

   Bats play an important role in many ecosystems around the world. They are a major predator of night-flying insects, including pests that cost farmers ...

6. Study of Selective BRAF Kinase Inhibitor Dabrafenib Monotherapy Twice Daily and in Combination with Dabrafenib Twice Daily and Trametinib Once Daily in Combination Therapy in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer - Mayo Clinic

   ... crossover subjects in Cohort A);; Anti-Cancer therapy including chemotherapy, radiation-therapy, immunotherapy, biologic therapy or major surgery within 14 ...

7. Spinal fusion - Doctors & Departments - Mayo Clinic

   This procedure connects two or more bones in the spine. The bones then can't move, which helps ease neck or back pain.

8. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

   Crossover Criteria: Participants must have been registered and received treatment in the IR arm, and must show progression of disease at any time during ...

9. A Study to Evaluate the Combination of Binimetinib and Palbociclib in Treating Patients with KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer - Mayo Clinic

   Crossover Inclusion Criteria: Age ≥18 years. Histological confirmation of colorectal cancer that is metastatic and/or unresectable. Documented mutation in ...

10. S1406 A Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer - Mayo Clinic

    Registration to Step 3 Crossover must be within 28 days of discontinuation of Arm 1 protocol treatment. patients going off treatment for any other reason are ...